HPI-363

N/A

Report date: 2025/06/11 11:08:36
NME

Base Information

Drug NameHPI-363
Drug Alias NameNeurotensin receptor-1 agonist (Emory University/JT Pharmaceuticals)ABS-363HPI-363
ClassificationSmall molecules
Mechanisms of ActionNeurotensin receptor 1 agonistsNeuroprotectants
TargetsNeurotensin receptor 1
Therapy Area/IndicationsIschemic StrokeMental DisordersFever +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEmory University
China Registration ClassN/A

Develop Information

Active CompaniesEmory UniversityJt Pharmaceuticals Inc
Inactive CompaniesHalimed Pharmaceuticals Inc
Active IndicationsIschemic StrokeMental DisordersFever +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A